UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘China’s healthcare market continues to grow rapidly’
China has witnessed a remarkable increase in the number of healthcare worke...
by Nam Doo-hyun
|
2018-12-28 14:45
라인
‘Demand for point-of-care devices to rise because of population aging’
With the population aging, the demand for point-of-care testing (POCT) devi...
by Nam Doo-hyun
|
2018-12-27 14:45
라인
‘Ministries should collaborate to enlarge surgical robotics market’
Korean government agencies should collaborate to accelerate the rapid growt...
by Nam Doo-hyun
|
2018-12-27 14:44
라인
Newly listed pharmaceuticals suffer market cap declines
Market capitalizations of pharmaceutical and biotech companies that went pu...
by Nam Doo-hyun
|
2018-12-21 15:13
라인
Consumer healthcare giant born out of GSK-Pfizer tie-up
Multinational drugmakers GSK and Pfizer said they would merge consumer heal...
by Nam Doo-hyun
|
2018-12-20 14:40
라인
Local firms rush to develop blinding disease treatments
The macular degeneration treatment market is heating up with local drugmake...
by Nam Doo-hyun
|
2018-12-20 14:37
라인
‘ASEAN provides growth opportunities for Korean healthcare firms’
The rising purchasing power of the Association of Southeast Asian Nations (...
by Nam Doo-hyun
|
2018-12-19 15:56
라인
Korea’s botulinum toxin exports rebound in November
Exports of botulinum toxin products, which had declined for several months,...
by Nam Doo-hyun
|
2018-12-18 15:51
라인
Will healthcare meetings restore investor confidence in pharmaceuticals?
Industry officials are looking what kind of positive issues will boost inve...
by Nam Doo-hyun
|
2018-12-17 15:44
라인
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun
|
2018-12-17 12:48
라인
New hepatitis C drugs compete in shrinking market
Despite the shrinking size of the hepatitis C treatment market with more pa...
by Nam Doo-hyun
|
2018-12-14 15:14
라인
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun
|
2018-12-13 15:33
라인
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun
|
2018-12-12 16:27
라인
‘Korea should protect pathogen resources under Nagoya Protocol’
With the value of pathogen resources heightening under Nagoya Protocol, Kor...
by Nam Doo-hyun
|
2018-12-10 15:15
라인
Trade ministry to support research of new biopharmaceutical drugs
The Ministry of Trade, Industry and Energy said it would aggressively help ...
by Nam Doo-hyun
|
2018-12-07 14:54
라인
Local drugmakers rank high in clinical trial approval
Domestic pharmaceutical companies took up over half of the top 20 drugmaker...
by Nam Doo-hyun
|
2018-12-06 11:15
라인
‘New combo drug could lower blood pressure early’
Amid an increase of hypertension drug prescriptions, new hypertension combi...
by Nam Doo-hyun
|
2018-12-05 14:01
라인
Doctors have fun on concert stage offered by drugmaker
The U Pharmaceutical, where employees are young enough to have fun, is a pl...
by Nam Doo-hyun
|
2018-12-04 14:31
라인
Prescriptions of anticancer drugs spiked this year
Prescriptions of anticancer medicines jumped during the first 10 months thi...
by Nam Doo-hyun
|
2018-11-30 13:01
라인
‘Rules to be tougher on patent transfer due to ToolGen case’
As the regulation on the patent transfer to a company from universities and...
by Nam Doo-hyun
|
2018-11-29 11:48
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top